Featured Research

from universities, journals, and other organizations

Finding Holds Promise For Treating Eye Disease And Cancer And For Healing Injuries

Date:
September 6, 2005
Source:
Schepens Eye Research Institute
Summary:
Scientists at Schepens Eye Research Institute have discovered that a particular immune cell contributes to the growth of new lymph vessels, which aid in healing. The discovery of this new role for the macrophage, published in the September 2005 Journal of Clinical Investigation, may ultimately inspire innovative treatments for blinding eye disease, as well as for other diseases, such as cancer, that rely on the lymph vessels to spread abnormal cells throughout the body.

Scientists at Schepens Eye Research Institute have discovered that aparticular immune cell contributes to the growth of new lymph vessels,which aid in healing. This cell, known as a macrophage, is called in bythe body during the wound healing process. The discovery of this newrole for the macrophage, published in the September 2005 Journal ofClinical Investigation, may ultimately inspire innovative treatmentsfor blinding eye disease, as well as for other diseases, such ascancer, that rely on the lymph vessels to spread abnormal cellsthroughout the body.

"This is a very significant finding," according to JoanStein-Streilein, PhD, and Patricia A. D'Amore, PhD, senior authors ofthe study, Senior Scientists at SERI and members of the Departments ofMedicine and Ophthalmology at Harvard Medical School, respectively. "Itunlocks a whole new dimension in our understanding of these importantcells."

The body uses lymph vessels to bring immune cells to an injured organto carry away debris and fluid to aid healing. Lymph vessels can play adifferent kind of role in cancer, offering tumor cells a pathway forspreading to other body parts, in a process known as metastasis.

Macrophages are large white blood cells called in during wound healingto ingest foreign invaders such as bacteria. They can also presentpieces of those intruders to the immune system to jump-start the immuneresponse. Produced in the bone marrow, they can be found in almost alltissues of the body. Unlike many other parts of the body, the clearouter layer of the eye, known as the cornea, does not normally havelymph vessels, except when injury causes lymph vessels to sprout fromthe edge of the cornea to help heal the wound.

Dr. Kazuichi Maruyama, a post-doctoral fellow in D'Amore's andStein-Streilein's laboratories at SERI, began to suspect a newconnection between macrophages and lymph vessels while studying cornealtransplants in mice. He became aware of lymph vessels that seemed to beforming "in place," away from those produced at the edge of the cornea.He also noticed that these lymph vessels disappeared after the woundswere healed. Because the cell structure of the new vessels resembledthat of macrophages, he began to believe there might be a relationship.

In the JCI study, he tested this idea by placing sutures in the corneasof two groups of mice to create injuries that would induce a healingresponse. Then he gave one group of mice a drug to cause macrophages tocommit suicide. When he examined the eyes of both groups, he foundthose given the drug did not grow as many lymph vessels as the controlgroup without the drug.

The implications of this link between macrophages and lymph vessels arefar-reaching, according to Stein-Streilein, D'Amore, and Maruyama.

D'Amore and Stein-Streilein believe that harnessing this newly foundability of the macrophages could lead to the creation of new drugs ortherapies for eye disease. For instance, inducing new "temporary" lymphvessels in retinas could aid in treating diabetic retinopathy byremoving fluids leaking from abnormal blood vessels. It is this leakingfluid, characteristic of diabetic retinopathy that can permanentlydamage the retina and vision.

Maruyama speculates that the involvement of macrophages in forminglymph vessels may be universal and may also be involved in spreadingcancer. If that were the case, blocking macrophages from helping togrow lymph vessels could inhibit the spread of tumors.

The team is now researching the same process in skin wounds and cancer.

###

SchepensEye Research Institute, and affiliate of Harvard Medical School, is thelargest independent eye research institute in the world.


Story Source:

The above story is based on materials provided by Schepens Eye Research Institute. Note: Materials may be edited for content and length.


Cite This Page:

Schepens Eye Research Institute. "Finding Holds Promise For Treating Eye Disease And Cancer And For Healing Injuries." ScienceDaily. ScienceDaily, 6 September 2005. <www.sciencedaily.com/releases/2005/09/050906074842.htm>.
Schepens Eye Research Institute. (2005, September 6). Finding Holds Promise For Treating Eye Disease And Cancer And For Healing Injuries. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2005/09/050906074842.htm
Schepens Eye Research Institute. "Finding Holds Promise For Treating Eye Disease And Cancer And For Healing Injuries." ScienceDaily. www.sciencedaily.com/releases/2005/09/050906074842.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins